Multimodal Techniques Failed to Detect Cytomegalovirus in Human Glioblastoma Samples

Overview

Journal J Neurovirol

Publisher Springer

Specialties Microbiology
Neurology

Date 2018 Nov 7

PMID 30397828

Citations 5

Authors

Marie-Pierre Loit

Homa Adle-Biassette

Schahrazed Bouazza

Marie-Christine Mazeron

Philippe Manivet

Jacqueline Lehmann-Che

Natacha Teissier

Emmanuel Mandonnet

Jean-Michel Molina

Affiliations

Soon will be listed here.

Abstract

The role of the human cytomegalovirus (HCMV) in gliomagenesis is largely debated. Contradictory data exist regarding the sensitivity and specificity of HCMV detection techniques, including immunohistochemistry (IHC), in situ hybridization (ISH), and RNA and DNA sequencing. The aim of this study is to detect HCMV in glioblastoma (GBM) tumor samples using IHC, ISH, and real-time PCR (qPCR), as well as to correlate the findings with serological status and HCMV DNA load in blood. Forty-seven patients with histopathological diagnosis of GBM and HCMV serological status were retrospectively reviewed. HCMV DNA quantification in whole blood was performed in 31 patients. The detection of HCMV in tumor samples was performed using IHC in 42 cases, ISH in 10 cases, and qPCR in 29 cases. All but two patients were taking high steroid doses at the time of biological testing. HCMV seroprevalence was 68%. Active infection with HCMV DNA detected in blood was diagnosed in 6 out of 21 (28%) seropositive patients. HCMV was not detected in GBM samples using IHC or ISH, while qPCR was positive in one case (also positive for blood HCMV DNA). These data do not support a crucial role of HCMV in GBM tumorigenesis. HCMV might be reactivated in GBM patients, due to steroid treatment.

Citing Articles

Cytomegalovirus-Specific Immunotherapy for Glioblastoma Treatments.

Ahn J, Shin C, Kim Y, Park J, Jeun S, Ahn S Brain Tumor Res Treat. 2022; 10(3):135-143.

PMID: 35929110 PMC: 9353163. DOI: 10.14791/btrt.2022.0010.

Molecular Investigation of Human Cytomegalovirus and Epstein-Barr virus in Glioblastoma Brain Tumor: A Case-Control Study in Iran.

Ghaffari H, Tavakoli A, Faranoush M, Naderi A, Kiani S, Sadeghipour A Iran Biomed J. 2021; 25(6):426-33.

PMID: 34696577 PMC: 8744698. DOI: 10.52547/ibj.25.6.426.

Presence of the Human Cytomegalovirus in Glioblastomas-A Systematic Review.

Peredo-Harvey I, Rahbar A, Soderberg-Naucler C Cancers (Basel). 2021; 13(20).

PMID: 34680198 PMC: 8533734. DOI: 10.3390/cancers13205051.

Predictive factors of human cytomegalovirus reactivation in newly diagnosed glioblastoma patients treated with chemoradiotherapy.

Ursu R, Doridam J, Chaugne E, Zannou H, Belin C, Cuzzubbo S J Neurovirol. 2021; 27(1):94-100.

PMID: 33405205 DOI: 10.1007/s13365-020-00922-4.

Fractalkine/CX3CL1 in Neoplastic Processes.

Korbecki J, Siminska D, Kojder K, Grochans S, Gutowska I, Chlubek D Int J Mol Sci. 2020; 21(10).

PMID: 32466280 PMC: 7279446. DOI: 10.3390/ijms21103723.

References

Cobbs C, Harkins L, Samanta M, Gillespie G, Bharara S, King P . Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002; 62(12):3347-50. View

Saper C, Sawchenko P . Magic peptides, magic antibodies: guidelines for appropriate controls for immunohistochemistry. J Comp Neurol. 2003; 465(2):161-3. DOI: 10.1002/cne.10858. View

Ward J . Controls for immunohistochemistry: is "brown" good enough?. Toxicol Pathol. 2004; 32(3):273-4. DOI: 10.1080/01926230490457585. View

Lau S, Chen Y, Chen W, Diamond D, Mamelak A, Zaia J . Lack of association of cytomegalovirus with human brain tumors. Mod Pathol. 2004; 18(6):838-43. DOI: 10.1038/modpathol.3800352. View

Stupp R, Mason W, van den Bent M, Weller M, Fisher B, Taphoorn M . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352(10):987-96. DOI: 10.1056/NEJMoa043330. View

Saper C . An open letter to our readers on the use of antibodies. J Comp Neurol. 2005; 493(4):477-8. DOI: 10.1002/cne.20839. View

Staras S, Dollard S, Radford K, Flanders W, Pass R, Cannon M . Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis. 2006; 43(9):1143-51. DOI: 10.1086/508173. View

Adle-Biassette H, Grassi J, Verney C, Walker F, Choudat L, Henin D . [The importance of controls in immunohistochemistry: how to validate an antibody, from research to diagnosis]. Ann Pathol. 2007; 27(1):16-26. DOI: 10.1016/s0242-6498(07)88680-9. View

Lowenberg M, Stahn C, Hommes D, Buttgereit F . Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids. 2008; 73(9-10):1025-9. DOI: 10.1016/j.steroids.2007.12.002. View

10.

Wen P, Kesari S . Malignant gliomas in adults. N Engl J Med. 2008; 359(5):492-507. DOI: 10.1056/NEJMra0708126. View

11.

Crough T, Khanna R . Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev. 2009; 22(1):76-98, Table of Contents. PMC: 2620639. DOI: 10.1128/CMR.00034-08. View

12.

Cannon M, Schmid D, Hyde T . Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010; 20(4):202-13. DOI: 10.1002/rmv.655. View

13.

Teissier N, Delezoide A, Mas A, Khung-Savatovsky S, Bessieres B, Nardelli J . Inner ear lesions in congenital cytomegalovirus infection of human fetuses. Acta Neuropathol. 2011; 122(6):763-74. DOI: 10.1007/s00401-011-0895-y. View

14.

Johnson D, Patrick ONeill B . Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol. 2011; 107(2):359-64. DOI: 10.1007/s11060-011-0749-4. View

15.

Dziurzynski K, Chang S, Heimberger A, Kalejta R, McGregor Dallas S, Smit M . Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol. 2012; 14(3):246-55. PMC: 3280809. DOI: 10.1093/neuonc/nor227. View

16.

Khoury J, Tannir N, Williams M, Chen Y, Yao H, Zhang J . Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq. J Virol. 2013; 87(16):8916-26. PMC: 3754044. DOI: 10.1128/JVI.00340-13. View

17.

Tang K, Alaei-Mahabadi B, Samuelsson T, Lindh M, Larsson E . The landscape of viral expression and host gene fusion and adaptation in human cancer. Nat Commun. 2013; 4:2513. PMC: 3806554. DOI: 10.1038/ncomms3513. View

18.

Yamashita Y, Ito Y, Isomura H, Takemura N, Okamoto A, Motomura K . Lack of presence of the human cytomegalovirus in human glioblastoma. Mod Pathol. 2013; 27(7):922-9. DOI: 10.1038/modpathol.2013.219. View

19.

Cosset E, Petty T, Dutoit V, Cordey S, Padioleau I, Otten-Hernandez P . Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene response. Int J Cancer. 2013; 135(6):1381-9. PMC: 4235296. DOI: 10.1002/ijc.28670. View

20.

Teissier N, Fallet-Bianco C, Delezoide A, Laquerriere A, Marcorelles P, Khung-Savatovsky S . Cytomegalovirus-induced brain malformations in fetuses. J Neuropathol Exp Neurol. 2014; 73(2):143-58. DOI: 10.1097/NEN.0000000000000038. View